Title Credit Type Event datesort descending Cost
ACC 2019: Duration Of Diabetes And Cardiorenal Efficacy Of Liraglutide And Semaglutide - Prof Subodh Verma Enduring £0.00
Utilizing NOAC's in non-valvular atrial fibrillation patients undergoing PCI
    • 0.00 Attendance
Enduring £0.00
Current and Emerging Data on SGLT2 Inhibitors in Heart Failure
    • 1.00 European Board for Accreditation in Cardiology (EBAC)
Enduring £0.00
Hybrid ablation: a role in AF management?
    • 1.00 European Board for Accreditation in Cardiology (EBAC)
Enduring £0.00
A Review of Emerging ARNI Data in HFrEF
    • 1.00 European Board for Accreditation in Cardiology (EBAC)
Enduring £0.00
Convergent procedure: A new approach to atrial fibrillation ablation
    • 1.00 European Board for Accreditation in Cardiology (EBAC)
Enduring £0.00